News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
97,973 Results
Type
Article (7124)
Company Profile (40)
Press Release (90805)
Multimedia
Podcasts (17)
Webinars (2)
Section
Business (27885)
Career Advice (128)
Deals (4016)
Drug Delivery (40)
Drug Development (14238)
Employer Resources (12)
FDA (3002)
Job Trends (2136)
News (49677)
Policy (6101)
Tag
2027 Pharm Country Standard (2)
Academia (434)
Accelerated approval (15)
Adcomms (7)
Allergies (46)
Alliances (9061)
ALS (34)
Alzheimer's disease (341)
Antibody-drug conjugate (ADC) (115)
Approvals (2977)
Artificial intelligence (125)
Autoimmune disease (51)
Automation (9)
Bankruptcy (19)
Best Places to Work (1803)
BIOSECURE Act (17)
Biosimilars (141)
Biotechnology (29)
Bladder cancer (42)
Brain cancer (14)
Breast cancer (129)
Cancer (1005)
Cardiovascular disease (51)
Career advice (116)
Career pathing (5)
CAR-T (49)
CDC (9)
Cell therapy (170)
Cervical cancer (8)
Clinical research (12398)
Collaboration (454)
Compensation (98)
Complete response letters (24)
COVID-19 (594)
CRISPR (12)
C-suite (163)
Cystic fibrosis (17)
Data (1397)
Denatured (6)
Depression (15)
Diabetes (73)
Diagnostics (606)
Digital health (6)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (88)
Drug pricing (42)
Drug shortages (1)
Duchenne muscular dystrophy (76)
Earnings (10201)
Editorial (16)
Employer branding (3)
Employer resources (10)
Events (12715)
Executive appointments (169)
FDA (3807)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (9)
Funding (290)
Gene editing (45)
Generative AI (18)
Gene therapy (182)
GLP-1 (150)
Government (1398)
Grass and pollen (1)
Guidances (81)
Healthcare (1955)
HIV (11)
Huntington's disease (14)
IgA nephropathy (20)
Immunology and inflammation (95)
Immuno-oncology (24)
Indications (23)
Infectious disease (661)
Inflammatory bowel disease (67)
Inflation Reduction Act (7)
Influenza (32)
Intellectual property (37)
Interviews (11)
IPO (1854)
IRA (16)
Job creations (388)
Job search strategy (108)
JPM (9)
Kidney cancer (3)
Labor market (8)
Layoffs (68)
Leadership (3)
Legal (567)
Liver cancer (13)
Longevity (9)
Lung cancer (154)
Lymphoma (71)
Machine learning (14)
Management (2)
Manufacturing (303)
MASH (30)
Medical device (1197)
Medtech (1209)
Mergers & acquisitions (2355)
Metabolic disorders (185)
Multiple sclerosis (41)
NASH (2)
Neurodegenerative disease (69)
Neuropsychiatric disorders (8)
Neuroscience (568)
NextGen: Class of 2026 (699)
Non-profit (359)
Now hiring (15)
Obesity (70)
Opinion (65)
Ovarian cancer (40)
Pain (23)
Pancreatic cancer (32)
Parkinson's disease (44)
Partnered (10)
Patents (72)
Patient recruitment (82)
Peanut (25)
People (8323)
Pharmaceutical (9)
Pharmacy benefit managers (7)
Phase 1 (4079)
Phase 2 (5143)
Phase 3 (4538)
Pipeline (1301)
Policy (120)
Postmarket research (301)
Preclinical (1600)
Press Release (66)
Prostate cancer (39)
Psychedelics (6)
Radiopharmaceuticals (42)
Rare diseases (197)
Real estate (930)
Recruiting (4)
Regulatory (5440)
Reports (11)
Research institute (397)
Resumes & cover letters (11)
Rett syndrome (5)
RNA editing (3)
RSV (17)
Schizophrenia (28)
Series A (51)
Series B (28)
Service/supplier (3)
Sickle cell disease (20)
Special edition (5)
Spinal muscular atrophy (23)
Sponsored (14)
Startups (593)
State (1)
Stomach cancer (5)
Supply chain (16)
Tariffs (21)
The Weekly (11)
Vaccines (292)
Venture capital (15)
Weight loss (29)
Women's health (7)
Date
Last 7 days (115)
Last 30 days (486)
Last 365 days (6034)
2026 (651)
2025 (6027)
2024 (6532)
2023 (6985)
2022 (9083)
2021 (9487)
2020 (8187)
2019 (5853)
2018 (4528)
2017 (5066)
2016 (4620)
2015 (5273)
2014 (3719)
2013 (2899)
2012 (2991)
2011 (3150)
2010 (2573)
Location
Africa (99)
Alabama (18)
Alaska (1)
Arizona (18)
Arkansas (2)
Asia (8013)
Australia (928)
California (2197)
Canada (430)
China (381)
Colorado (48)
Connecticut (58)
Delaware (99)
Europe (14605)
Florida (302)
Georgia (39)
Hawaii (1)
Idaho (14)
Illinois (95)
India (34)
Indiana (57)
Iowa (10)
Japan (97)
Kansas (7)
Kentucky (13)
Louisiana (2)
Maine (5)
Maryland (444)
Massachusetts (1605)
Michigan (32)
Minnesota (75)
Mississippi (4)
Missouri (23)
Montana (5)
Nebraska (1)
Nevada (12)
New Hampshire (5)
New Jersey (738)
New Mexico (4)
New York (562)
North Carolina (296)
North Dakota (9)
Northern California (1056)
Ohio (64)
Oklahoma (11)
Oregon (5)
Pennsylvania (316)
Puerto Rico (2)
Rhode Island (6)
South America (140)
South Carolina (3)
Southern California (916)
Tennessee (7)
Texas (325)
United States (7490)
Utah (43)
Virginia (27)
Washington D.C. (8)
Washington State (172)
West Virginia (1)
Wisconsin (15)
97,973 Results for "agc biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sponsored
Cracking the Code: Solving Microbial Manufacturing’s Biggest Challenges
Perfecting microbial manufacturing processes means taming its greatest asset: speed. This rapid process for creating biologics also means a race against time, where success hinges on conquering three key challenges: designing a robust microbial strain, optimizing fermentation for industrial scale, and ensuring consistent high-yield product yield.
December 1, 2025
·
6 min read
·
AGC Biologics
Press Releases
AGC Biologics Seattle Site Now Certified to Manufacture Biologics for Largest Pharmaceutical Market in South America
February 4, 2026
·
4 min read
Press Releases
AGC Biologics Celebrates U.S. and EU Approval of Fondazione Telethon’s Waskyra™ Treatment for Wiskott-Aldrich Syndrome
January 19, 2026
·
4 min read
Press Releases
Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
January 12, 2026
·
3 min read
Press Releases
AGC Biologics to Manufacture AAVantgarde’s Dual-Vector Gene Therapies for Inherited Retinal Disorders
November 21, 2025
·
4 min read
Press Releases
AGC Biologics and Repair Biotechnologies Partner on Novel mRNA Therapeutic to Combat the Leading Cause of Human Mortality
November 19, 2025
·
4 min read
Press Releases
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient
January 12, 2026
·
3 min read
Press Releases
European Commission Approves CAR-T Therapy With Lentiviral Vectors Manufactured by AGC Biologics
August 1, 2025
·
3 min read
Sponsored
After the JPM Hype, a Reality Check: Why your 2026 Strategy Hinges on your Manufacturing Toolkit
After J.P. Morgan, biotech’s bold promises meet real-world challenges. In 2026, success starts with a CDMO partner who accelerates timelines and anticipates every manufacturing hurdle. Learn how AGC Biologics offers tailored cell line solutions for complex molecules.
January 19, 2026
·
3 min read
Press Releases
AGC Biologics Expands Cell Therapy Development Operations to Asia to Serve Growing Market Need
June 26, 2025
·
3 min read
1 of 9,798
Next
